南模生物受邀参加INT2019第三届免疫及新型治疗技术峰会并取得圆满成功
2019年7月5日-6日INT第三届免疫及新型治疗技术峰会在北京圆满召开。大会分为四大主题论坛，共有40+的行业专家带来精彩演讲，吸引了400+业界同仁参会。南模生物受邀参展。
图 会议现场展台。
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
